Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'470 1.7%  SPI 13'410 1.7%  Dow 29'491 2.7%  DAX 12'511 2.5%  Euro 0.9747 0.0%  EStoxx50 3'437 2.8%  Gold 1'706 0.4%  Bitcoin 19'688 1.1%  Dollar 0.9888 -0.4%  Öl 89.6 1.1% 

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
11.08.2022 21:18:17

Why Wave Life Sciences Was Zooming Higher Today

There was a great deal of life in Wave Life Sciences (NASDAQ: WVE) stock on Thursday. As of midafternoon trading, investors had bid the company's share price up by more than 25%, comparing very favorably to the marginal gain eked out by the S&P 500 index. That was due almost entirely to the clinical-stage biotech's latest set of quarterly results and business update. Before market open, Wave published its second-quarter results. These showed that, although the company is mostly pre-revenue at this stage of its existence, it nevertheless booked $375,000 on the top line. This was down from the nearly $2.8 million it earned in the same quarter last year.Somewhat predictably net loss deepened, but not by a significant amount. It came in at slightly more than $41 million ($0.62 per share), against the year-ago deficit of almost $39 million.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

INFLATION: WELTWEIT STEIGEN DIE PREISE

Viele Anleger setzen deshalb auf den Aktiv verwalteten Global Inflation Protection Basket. Informieren Sie sich über die breit gestreute Auswahl an robusten Aktien & ETFs.